Single award · contract
Award of 10M Treatment Courses of Oral Protease Inhibitor PF-07321332
Award ID: W58P0522C0001
FY2022 · complete year · data as of 2026-07-11
A single federal award, with both ends of the trail linked.
$12.5B
Total award value
Award W58P0522C0001 is a contract from the Department of Defense to Pfizer Inc, $12.5B obligated, FY2022 to FY2023, for Award of 10M Treatment Courses of Oral Protease Inhibitor PF-07321332. The work is performed in New York. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Source
Agency ›
Department of Defense
Source
awarded→$12.5B
Recipient ›
Pfizer Inc
Source
performed in→
Award details
Award typeContract
PIIDW58P0522C0001
Action date2021
Period16 mo
Awarding agencyDepartment of Defense →
RecipientPfizer Inc →
Place of performanceNew York →
CategoryNAICS 325412PSC 6505
Competed?Not recordedSource
Total (exact)$12,549,999,848
More awards to Pfizer Inc
awarded 2020$11.1B
awarded 2021$4.2B
awarded 2022$4B
awarded 2014$1B
awarded 2017$1B
More from Department of Defense
awarded 2016$51.3B
awarded 2017$35.7B
awarded 2017$35.1B
awarded 2001$34.2B
awarded 2011$32B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.